Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/CTRI/2018/02/011987
CTRI/2018/02/011987Completed未知

Frequency of Circulating Tumor Cells (CTCs) and Amount of Cell-free DNA (cfDNA) in Cirrhotic Patients With Hepatocellular Carcinoma (HCC): A case control study

Institute of liver and Biliary Sciences0 sites53 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
未知
Status
Completed
Enrollment
53
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Inclusion Criteria

  • •1) Age between 18-70 years.
  • •2) Proven cirrhosis (Defined in appendix 1).
  • •3) HCC proven by standard radiological criteria within last 1-month
  • •4) No HCC on dynamic CT and/or dynamic MRI (protocol defined in appendix 1) done within last 1 month

Exclusion Criteria

  • •1) Previous biopsy or FNA of the tumor.1
  • •2) Previous invasive radiological procedures TACE/RFA.
  • •3) Previous or ongoing chemotherapy or biological therapy.
  • •4) Previous liver resection or transplant.
  • •5) Segmental / main PV thrombosis.2
  • •6) Atypical enhancement on imaging
  • •7) Extrahepatic metastatic spread of HCC3
  • •8) Coexisting sepsis.
  • •9) Renal dysfunction, as defined by serum creatinine >1.5mg/dL.5

Investigators

Similar Trials

Recruiting
Not Applicable
Determining Circulating Tumour Cells (CTC) and other rare cells in cancer patients and for early detection screeningCancer
ACTRN12614001143617Dr Karin Ried2,000
Recruiting
Not Applicable
CTCs in Lung Malignancies
CTRI/2021/08/035450Datar Cancer Genetics Private Limited
Recruiting
Not Applicable
Analysis of circulating tumor cells(CTCs) and clinical significance of CTCs; human atrial natriuretic peptide during perioperative period for completely resected non-small cell lung cancer: a multicentre, open-label, randomised controlled trialnon-small cell lung cancer
JPRN-UMIN000024302Osaka University Graduate School of Medicine500
Withdrawn
Not Applicable
Effectiveness of monitoring levels of Circulating Tumour Cells (CTCs) in blood for early detection and treatment monitoring in cancer patients.Cancer
ACTRN12617001496303Survon Pte Ltd300
Active, not recruiting
Not Applicable
Evaluation of Circulating Tumors Cells (CTCs) as Potential Surrogate Marker for Further Definition und Subclassification of non metastatic High-Risk Castration Resistant Prostate Cancer PatientsC61Malignant neoplasm of prostateprostate cancer
DRKS00008554OnkoDataMed GmbH5
Observational study in hepatocellular... | Clinical Trial